Clinical Trials on Relapsed Hodgkin Lymphoma
Total 59661 results
-
Genta IncorporatedCompletedNon-Hodgkin's Lymphoma | Refractory Lymphoma | Relapsed Lymphoma | Low-Grade Lymphoma | Intermediate-Grade LymphomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterAmerican Society of Clinical OncologyRecruitingRefractory Hodgkin Lymphoma | Relapsed Hodgkin LymphomaUnited States
-
Molecular Templates, Inc.TerminatedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell Lymphoma | Non-hodgkin Lymphoma,B CellUnited States
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cells Non-Hodgkin LymphomaItaly
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
Janssen Research & Development, LLCMayo ClinicRecruitingRelapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Australia, Israel
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory B-cell Non-Hodgkin LymphomaUnited States, Korea, Republic of, Canada, United Kingdom, Spain, France, Denmark
-
AbbVie (prior sponsor, Abbott)CompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Peripheral T-cell Lymphoma | Lymphoid Malignancies | Chronic Lymphoid LeukemiaUnited States, Canada
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI)WithdrawnAnaplastic Large Cell Lymphoma | AIDS-related Lymphoma | Adult Non-Hodgkin's Lymphoma
-
National Cancer Institute (NCI)TerminatedAcute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Non-Hodgkins Lymphoma | Hodgkins LymphomaUnited States
-
Sohag UniversityNot yet recruiting
-
Centre Hospitalier Universitaire DijonRecruitingNon-hodgkin's LymphomaFrance
-
Xynomic Pharmaceuticals, Inc.Cancer Institute and Hospital, Chinese Academy of Medical SciencesActive, not recruitingNon Hodgkin LymphomaChina
-
MorphoSys AGCompletedNon-Hodgkin LymphomaUnited States, Belgium, Germany, Hungary, Italy, Poland, Spain
-
Gilead SciencesTerminated
-
Assiut UniversityCompleted
-
Novartis PharmaceuticalsCompletedNeoplasms | Non-Hodgkin LymphomaUnited States, Netherlands
-
Institut Paoli-CalmettesCompletedNon-Hodgkin LymphomaFrance
-
University of BelgradeUnknownNon-hodgkin LymphomaSerbia
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.The First Affiliated Hospital of Zhengzhou UniversityUnknown
-
Nordic NanovectorWithdrawnNon-Hodgkin LymphomaGermany
-
Samsung Medical CenterMillennium Pharmaceuticals, Inc.CompletedNon-Hodgkin LymphomaKorea, Republic of
-
Beijing Immunochina Medical Science & Technology...Peking University Cancer Hospital & InstituteUnknownNon Hodgkin LymphomaChina
-
Centre Leon BerardAmgenTerminated
-
Radboud University Medical CenterUnknown
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Genzyme, a Sanofi CompanyCompleted
-
Asociacion Espanola de Hematologia y HemoterapiaCompleted
-
Instituto Nacional de Cancerologia de MexicoUnknownNon-Hodgkin LymphomaMexico
-
Chiron CorporationTerminatedNon-Hodgkin LymphomaUnited States
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin Disease | Peripheral T Cell LymphomaUnited States, Canada
-
University of WashingtonJanssen PharmaceuticalsActive, not recruitingRecurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
Tessa TherapeuticsBristol-Myers SquibbActive, not recruitingClassical Hodgkin Lymphoma | Hodgkin Disease Recurrent | Hodgkin Disease RefractoryUnited States
-
Institut Paoli-CalmettesCompletedHodgkin Lymphoma | Acute Leukemia | Non-hodgkin Lymphoma | Malignant HaemopathiesFrance
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
John ReneauRecruitingRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Adult T-Cell Leukemia/LymphomaUnited States
-
Samsung Medical CenterCompletedPrimary Mediastinal Large B-cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaKorea, Republic of
-
Genentech, Inc.Completed
-
Cellectis S.A.RecruitingB-cell Non-Hodgkin Lymphoma (B-NHL)United States, Spain, France
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
University of CologneNovartisTerminated
-
Masonic Cancer Center, University of MinnesotaCompletedDiffuse Large B Cell Non-Hodgkin LymphomaUnited States
-
Samsung Medical CenterCompletedRelapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin LymphomaKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.; Hôpitaux Universitaires Henri Mondor, FranceCompletedHodgkin's LymphomaUnited States
-
ItalfarmacoCompleted
-
Syndax PharmaceuticalsTerminatedHodgkin's LymphomaUnited States
-
TG Therapeutics, Inc.CompletedHodgkin's LymphomaUnited States
-
Novartis PharmaceuticalsCompletedHodgkin's LymphomaUnited States, Belgium, Germany, Canada, Singapore, Netherlands, France, Australia, Russian Federation, Israel, Brazil, Italy, New Zealand, Poland
-
Ospedale Santa Croce-Carle CuneoFondazione Italiana Linfomi ONLUS; Consorzio Mario Negri SudUnknownHodgkin's LymphomaItaly
-
Mirati Therapeutics Inc.TerminatedHodgkin's LymphomaUnited States, Canada